The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glucuronolactone Market Research Report 2024
Synopsis
Glucuronolactone is a naturally occurring substance that is an important structural component of nearly all connective tissues.Glucuronolactone is also found in many plant gums.
The global Glucuronolactone market was valued at US$ 253.4 million in 2023 and is anticipated to reach US$ 333.8 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
North American market for Glucuronolactone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glucuronolactone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glucuronolactone include Ceto Corporation, Anhui Fubore Pharmaceutical & Chemical, Creative Compounds, Foodchem International, Hubei Yitai Pharmaceutical, Merck Millipore, Shaoxing Marina Biotechnology, Shouguang Zhonghe Biochemical and Suzhou Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glucuronolactone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucuronolactone.
Report Scope
The Glucuronolactone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucuronolactone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucuronolactone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ceto Corporation
Anhui Fubore Pharmaceutical & Chemical
Creative Compounds
Foodchem International
Hubei Yitai Pharmaceutical
Merck Millipore
Shaoxing Marina Biotechnology
Shouguang Zhonghe Biochemical
Suzhou Pharmaceutical Group
Segment by Type
Medical
Food
Segment by Application
Pharmaceuticals
Food & Beverage
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucuronolactone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucuronolactone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Glucuronolactone is a naturally occurring substance that is an important structural component of nearly all connective tissues.Glucuronolactone is also found in many plant gums.
The global Glucuronolactone market was valued at US$ 253.4 million in 2023 and is anticipated to reach US$ 333.8 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
North American market for Glucuronolactone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glucuronolactone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glucuronolactone include Ceto Corporation, Anhui Fubore Pharmaceutical & Chemical, Creative Compounds, Foodchem International, Hubei Yitai Pharmaceutical, Merck Millipore, Shaoxing Marina Biotechnology, Shouguang Zhonghe Biochemical and Suzhou Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glucuronolactone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucuronolactone.
Report Scope
The Glucuronolactone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucuronolactone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucuronolactone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ceto Corporation
Anhui Fubore Pharmaceutical & Chemical
Creative Compounds
Foodchem International
Hubei Yitai Pharmaceutical
Merck Millipore
Shaoxing Marina Biotechnology
Shouguang Zhonghe Biochemical
Suzhou Pharmaceutical Group
Segment by Type
Medical
Food
Segment by Application
Pharmaceuticals
Food & Beverage
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucuronolactone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucuronolactone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Glucuronolactone Market Overview
1.1 Product Overview and Scope of Glucuronolactone
1.2 Glucuronolactone Segment by Type
1.2.1 Global Glucuronolactone Market Value Comparison by Type (2024-2030)
1.2.2 Medical
1.2.3 Food
1.3 Glucuronolactone Segment by Application
1.3.1 Global Glucuronolactone Market Value by Application: (2024-2030)
1.3.2 Pharmaceuticals
1.3.3 Food & Beverage
1.4 Global Glucuronolactone Market Size Estimates and Forecasts
1.4.1 Global Glucuronolactone Revenue 2019-2030
1.4.2 Global Glucuronolactone Sales 2019-2030
1.4.3 Global Glucuronolactone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glucuronolactone Market Competition by Manufacturers
2.1 Global Glucuronolactone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glucuronolactone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glucuronolactone Average Price by Manufacturers (2019-2024)
2.4 Global Glucuronolactone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucuronolactone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucuronolactone, Product Type & Application
2.7 Glucuronolactone Market Competitive Situation and Trends
2.7.1 Glucuronolactone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glucuronolactone Players Market Share by Revenue
2.7.3 Global Glucuronolactone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucuronolactone Retrospective Market Scenario by Region
3.1 Global Glucuronolactone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glucuronolactone Global Glucuronolactone Sales by Region: 2019-2030
3.2.1 Global Glucuronolactone Sales by Region: 2019-2024
3.2.2 Global Glucuronolactone Sales by Region: 2025-2030
3.3 Global Glucuronolactone Global Glucuronolactone Revenue by Region: 2019-2030
3.3.1 Global Glucuronolactone Revenue by Region: 2019-2024
3.3.2 Global Glucuronolactone Revenue by Region: 2025-2030
3.4 North America Glucuronolactone Market Facts & Figures by Country
3.4.1 North America Glucuronolactone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glucuronolactone Sales by Country (2019-2030)
3.4.3 North America Glucuronolactone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glucuronolactone Market Facts & Figures by Country
3.5.1 Europe Glucuronolactone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glucuronolactone Sales by Country (2019-2030)
3.5.3 Europe Glucuronolactone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucuronolactone Market Facts & Figures by Country
3.6.1 Asia Pacific Glucuronolactone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glucuronolactone Sales by Country (2019-2030)
3.6.3 Asia Pacific Glucuronolactone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glucuronolactone Market Facts & Figures by Country
3.7.1 Latin America Glucuronolactone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glucuronolactone Sales by Country (2019-2030)
3.7.3 Latin America Glucuronolactone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucuronolactone Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucuronolactone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glucuronolactone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glucuronolactone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glucuronolactone Sales by Type (2019-2030)
4.1.1 Global Glucuronolactone Sales by Type (2019-2024)
4.1.2 Global Glucuronolactone Sales by Type (2025-2030)
4.1.3 Global Glucuronolactone Sales Market Share by Type (2019-2030)
4.2 Global Glucuronolactone Revenue by Type (2019-2030)
4.2.1 Global Glucuronolactone Revenue by Type (2019-2024)
4.2.2 Global Glucuronolactone Revenue by Type (2025-2030)
4.2.3 Global Glucuronolactone Revenue Market Share by Type (2019-2030)
4.3 Global Glucuronolactone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glucuronolactone Sales by Application (2019-2030)
5.1.1 Global Glucuronolactone Sales by Application (2019-2024)
5.1.2 Global Glucuronolactone Sales by Application (2025-2030)
5.1.3 Global Glucuronolactone Sales Market Share by Application (2019-2030)
5.2 Global Glucuronolactone Revenue by Application (2019-2030)
5.2.1 Global Glucuronolactone Revenue by Application (2019-2024)
5.2.2 Global Glucuronolactone Revenue by Application (2025-2030)
5.2.3 Global Glucuronolactone Revenue Market Share by Application (2019-2030)
5.3 Global Glucuronolactone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ceto Corporation
6.1.1 Ceto Corporation Corporation Information
6.1.2 Ceto Corporation Description and Business Overview
6.1.3 Ceto Corporation Glucuronolactone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ceto Corporation Glucuronolactone Product Portfolio
6.1.5 Ceto Corporation Recent Developments/Updates
6.2 Anhui Fubore Pharmaceutical & Chemical
6.2.1 Anhui Fubore Pharmaceutical & Chemical Corporation Information
6.2.2 Anhui Fubore Pharmaceutical & Chemical Description and Business Overview
6.2.3 Anhui Fubore Pharmaceutical & Chemical Glucuronolactone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Anhui Fubore Pharmaceutical & Chemical Glucuronolactone Product Portfolio
6.2.5 Anhui Fubore Pharmaceutical & Chemical Recent Developments/Updates
6.3 Creative Compounds
6.3.1 Creative Compounds Corporation Information
6.3.2 Creative Compounds Description and Business Overview
6.3.3 Creative Compounds Glucuronolactone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Creative Compounds Glucuronolactone Product Portfolio
6.3.5 Creative Compounds Recent Developments/Updates
6.4 Foodchem International
6.4.1 Foodchem International Corporation Information
6.4.2 Foodchem International Description and Business Overview
6.4.3 Foodchem International Glucuronolactone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Foodchem International Glucuronolactone Product Portfolio
6.4.5 Foodchem International Recent Developments/Updates
6.5 Hubei Yitai Pharmaceutical
6.5.1 Hubei Yitai Pharmaceutical Corporation Information
6.5.2 Hubei Yitai Pharmaceutical Description and Business Overview
6.5.3 Hubei Yitai Pharmaceutical Glucuronolactone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hubei Yitai Pharmaceutical Glucuronolactone Product Portfolio
6.5.5 Hubei Yitai Pharmaceutical Recent Developments/Updates
6.6 Merck Millipore
6.6.1 Merck Millipore Corporation Information
6.6.2 Merck Millipore Description and Business Overview
6.6.3 Merck Millipore Glucuronolactone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck Millipore Glucuronolactone Product Portfolio
6.6.5 Merck Millipore Recent Developments/Updates
6.7 Shaoxing Marina Biotechnology
6.6.1 Shaoxing Marina Biotechnology Corporation Information
6.6.2 Shaoxing Marina Biotechnology Description and Business Overview
6.6.3 Shaoxing Marina Biotechnology Glucuronolactone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shaoxing Marina Biotechnology Glucuronolactone Product Portfolio
6.7.5 Shaoxing Marina Biotechnology Recent Developments/Updates
6.8 Shouguang Zhonghe Biochemical
6.8.1 Shouguang Zhonghe Biochemical Corporation Information
6.8.2 Shouguang Zhonghe Biochemical Description and Business Overview
6.8.3 Shouguang Zhonghe Biochemical Glucuronolactone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shouguang Zhonghe Biochemical Glucuronolactone Product Portfolio
6.8.5 Shouguang Zhonghe Biochemical Recent Developments/Updates
6.9 Suzhou Pharmaceutical Group
6.9.1 Suzhou Pharmaceutical Group Corporation Information
6.9.2 Suzhou Pharmaceutical Group Description and Business Overview
6.9.3 Suzhou Pharmaceutical Group Glucuronolactone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Suzhou Pharmaceutical Group Glucuronolactone Product Portfolio
6.9.5 Suzhou Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucuronolactone Industry Chain Analysis
7.2 Glucuronolactone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucuronolactone Production Mode & Process
7.4 Glucuronolactone Sales and Marketing
7.4.1 Glucuronolactone Sales Channels
7.4.2 Glucuronolactone Distributors
7.5 Glucuronolactone Customers
8 Glucuronolactone Market Dynamics
8.1 Glucuronolactone Industry Trends
8.2 Glucuronolactone Market Drivers
8.3 Glucuronolactone Market Challenges
8.4 Glucuronolactone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
